Protective effects of xanthones against myocardial ischemia-reperfusion injury in rats

Acta Pharmacologica Sinica

Volumn 24, Issue 2, 2003, Pages 175-180

  Jiang, De Jian ^a   Tan, Gui Shan ^a   Feng, Ye ^a   Du, Yan Hua ^a   Xu, Kang Ping ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Heart function tests; Lipid peroxidation; Myocardial reperfusion injury; Swertia davidi Franch; Xanthone

Indexed keywords

VERAPAMIL; XANTHONE 4 ACETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; EFFLUENT; ENZYME ACTIVITY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART RATE; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; CREATINE KINASE; HEART; HEART RATE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PLANTS, MEDICINAL; RATS; RATS, WISTAR; SWERTIA; VENTRICULAR PRESSURE; XANTHONES;

EID: 0037311188     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Peres V, Nagem TJ, de Oliveira FF. Tetraoxygenerated naturally occurring xanthones. Phytochemistry 2000; 55: 683-710.
2. Gonda R, Takeda T, Akiyama T. Studies on the constituents of Anaxagorea luzonensis A. GRAY. Chem Pharm Bull (Tokyo) 2000; 48: 1219-22.
3. Minami H, Takahashi E, Fukuyama Y, Kodama M, Yoshizawa T, Nakagawa K. Novel xanthones with superoxide scavenging activity from Garcinia subelliptica. Chem Pharm Bull (Tokyo) 1995; 43: 347-9.
4. Chang CH, Lin CC, Hattori M, Namba T. Effects on antilipid peroxidation of Cudrania cochinchinensis var gerontogea. J Ethnopharmacol 1994; 44: 79-85.
5. Mahabusarakam W, Proudfoot J, Taylor W, Croft K. Inhibition of lipoprotein oxidation by prenylatted xanthones derived from mangostin. Free Radic Res 2000; 33: 643-59.
6. He QH, Xu SB, Peng B. Mechanism of Canscora lucidissima xanthones against arrhythmia induced by myocardial ischemia reperfusion in rats. China J Chin Mater Med 1998; 23: 556-7.
7. Librowski T, Czarnecki R, Jastrzebska M. Chiral 2-amino- 1-butanol xanthone derivatives as potential antiarrhythmic and hypotensive agents. Acta Pol Pharm 1999; 56; 87-9.
8. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989: 80: 1049-62.
9. Goldhaber JI, Weiss JN. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 1992; 20: 118-27
10. Marban E, Koretsune Y, Corretti M, Chacko VP, Kusuoke H. Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation 1989; 80 (6 Suppl): IV17-IV22.
11. Koerner JE, Anderson BA, Dage RC. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals: superoxide dismutase plus catalase, N-2-mercaptopropionyl glycine and captopril. J Cardiovasc Pharmcol 1991; 17: 185-91.
12. Hong CY, Huang SS, Tsai SK. Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation, Clin Exp Pharmcol Physiol 1996; 23: 660-4.
13. Huang CH, Hong CY, Tsai SK, Lai ST, Weng ZC, Chih CL, et al. Intravenous pretreatment with magnolol protects myocardium against stunning, Planta Med 2000; 66: 516-20,
14. Carini M, Aldini G, Rossoni G, Morazzoni P, Facino RM. Complexation of Ginkgo biloba extract with phosphatidylcholine improves cardioprotective activity and increases the plasma antioxidant capacity in the rat. Planta Med 2001; 67: 326-30.
15. Haramaki N, Aggarwal S, Kawabata T, Droy-Lefaix MT, Packer L. Effects of natural antioxidant Ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury. Free Radic Bio Med 1994; 16: 789-94.
16. Li YJ, Deng HW, Chen X. Prevention of lipid peroxidation of prostacyclin synthesis by verapamil in ischemic myocardium of rat. Chin J Pharmacol Toxicol 1988; 2: 161-5.
17. Cheng YW, Kang JJ. Mechanism of vasorelaxation of thoracic aorta caused by xanthone. Eur J Pharmacol 1997; 336: 23-8.
18. Bisi A, Budriesi R, Rampa A, Fabbri G, Chiarini A, Valenti P. Synthesis and pharmacological profile of some chloroxanthone-1,4-dihydropyridine derivatives. Arzneimittelforschung 1996; 46: 848-51.
19. + exchange system. Chin Pharmacol Bull 2000; 16: 642-4.
20. + exchanger contributes to cardiac damage following ischaemia and reperfusion. Clin Exp Pharmacol Physiol 2000; 27: 727-33.
21. + exchange inhibitor, on ischemia-reperfusion-injured hearts. J Cardiovasc Pharmacol 2001; 37: 143-54.
22. + exchange inhibitor, on ischemia/reperfusion injury. Eur J Pharmacol 2000; 404: 221-9.
23. Obata T, Yamanaka Y. Protective effect of diltiazem on myocardial ischemic injury associated with OH generation. Comp Biochem Physiol A Physiol 1997; 117: 257-61.
24. Wang WQ, Ma CG, Xu SY. Protective effect of hyperin against myocardial ischemia and reperfusion injury. Acta Pharmacol Sin 1996; 17: 341-4.